Aurora Cannabis one of 3 chosen to supply German medical market
-
Share on Facebook
-
Share on Twitter
- Copy Link
EDMONTON, AB. — Aurora Cannabis and Aphria Inc. say they were among the three companies selected by the German government to cultivate and distribute medical pot in the European country.
Both companies say the decision by Germany’s Federal Institute for Drugs and Medical Devices is provisional and subject to a mandatory 10-day waiting period, which allows unsuccessful bidders to submit a challenge before the final contract is signed.
If finalized, the cannabis produced by both Aurora and Aphria will supply the German medical cannabis market, which is the largest in Europe according to a recent report by Brightfield Group.
Jefferies analyst Owen Bennett says the news is positive for Aurora, as it helps to validate the quality of its medical operations and puts the Edmonton-based company in good stead when attempting to enter other markets.
